4 results
Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months
-
- Journal:
- European Psychiatry / Volume 63 / Issue 1 / 2020
- Published online by Cambridge University Press:
- 07 August 2020, e83
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Stability and development of psychotic symptoms and the use of antipsychotic medication – long-term follow-up
-
- Journal:
- Psychological Medicine / Volume 47 / Issue 12 / September 2017
- Published online by Cambridge University Press:
- 06 April 2017, pp. 2118-2129
-
- Article
- Export citation
Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial
-
- Journal:
- Psychological Medicine / Volume 44 / Issue 1 / January 2014
- Published online by Cambridge University Press:
- 16 April 2013, pp. 117-126
-
- Article
- Export citation
Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial
-
- Journal:
- Psychological Medicine / Volume 43 / Issue 7 / July 2013
- Published online by Cambridge University Press:
- 08 October 2012, pp. 1499-1510
-
- Article
- Export citation